FEB 09, 2017 12:48 PM PST

New Mechanism For How Aspirin Fights Cancer

WRITTEN BY: Xuan Pham

Aspirin, the ultra-cheap drug that’s ubiquitous in nearly everyone’s medicine cabinet, has a long been implicated as an anticancer drug. Strangely, however, the mechanisms of its purported anticancer effects have always been vague. Now, scientists say that it’s not the anti-inflammatory power of aspirin that thwarts cancer; rather, they think it’s because of aspirin’s effects on blood clotting.

Formally known as acetylsalicylic acid (ASA), aspirin is one of the cheapest and most widely used over-the-counter drugs. This humble drug is used to treat a variety of health conditions like the common fevers, headaches, and inflammation. Doctors also prescribe this drug to reduce the risk of heart attacks for patients who have already had one.

In recent years, aspirin gained the spotlight again as more research linked it to anti-cancer potential. Studies have previously linked aspirin to lowering the risks for colorectal and colon cancer by close to 20 percent.

As to why aspirin is such a miracle drug, researchers typically point out its anti-inflammatory properties. But in examining the mechanism behind aspirin’s effects, researchers at the Veteran’s Affairs in Texas found that aspirin may also affect platelets –blood cells that form clots to protect against bleeding out.

In particular, the team studied aspirin’s effects in cell cultures and mice. They found that ASA reduced the level of COX-1, an enzyme that revs up the body’s inflammatory responses. As a result, less platelets are able to circulate in the bloodstream, which reduces the chances of interaction between platelets and cancer cells.

As the team reports, platelets are useful in stopping bleeding. However, cancer can subvert these cells for its own growth. Thus, reducing platelet circulation may be the mechanism behind how aspirin lowers cancer risks.

"These results suggest that aspirin's chemopreventive effects may be due, in part, to the drug blocking the proneoplastic [supporting new, abnormal growth, as in cancer] action of platelets and [they support] the potential use of Aspirin-PC/PL2200 as an effective and safer chemopreventive agent for colorectal cancer and possibly other cancers,” the team reported in Cancer Prevention Research.

The team will next test aspirin’s safety and efficacy in people with colorectal cancer. In the mean time, they say the results "support the use of low-dose aspirin for chemoprevention."

So, does an aspirin a day keep cancer at bay? You and your doctor decide.

Additional sources: Veterans Affairs Research Communications

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
AUG 24, 2021
Clinical & Molecular DX
A New Chapter in Metastatic Breast Cancer Biomarkers
AUG 24, 2021
A New Chapter in Metastatic Breast Cancer Biomarkers
For patients diagnosed with metastatic breast cancer, it’s often not the primary tumor that has fatal consequences ...
SEP 18, 2021
Genetics & Genomics
Cancer Genes Might Aim for the Immune System, Not Growth Promotion
SEP 18, 2021
Cancer Genes Might Aim for the Immune System, Not Growth Promotion
The DNA in our cells can accumulate damage over may years. Environmental influences like UV light or cigarette smoke may ...
OCT 07, 2021
Cell & Molecular Biology
Color-Changing Slides Improve Accuracy in Cancer Diagnosis
OCT 07, 2021
Color-Changing Slides Improve Accuracy in Cancer Diagnosis
When cancer is diagnosed, a sample has to be taken from a patient, treated, and analyzed. Researchers have now modified ...
OCT 14, 2021
Clinical & Molecular DX
Weighing Cancer Cells Helps Predict Treatment Outcomes
OCT 14, 2021
Weighing Cancer Cells Helps Predict Treatment Outcomes
Not all cancer patients respond to oncology treatments in the same way. Some might show signs of improvement as the ther ...
OCT 25, 2021
Cell & Molecular Biology
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
OCT 25, 2021
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
Labroots virtual events are a great place to share research and learn about others work. These events feature participan ...
Loading Comments...